Keppra · DIN 02247028 · 500 mg · tablet
Limited Use, Reason for Use code 473 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 473 required
Write on scriptReason for Use code 473 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 473
Reason for Use code 473
As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Keppra · DIN 02247028
Manufacturer: UCB Canada Inc.; listing date 2007-11-10
Health Canada: Marketed since 2010-09-13 · brand KEPPRA · ATC N03AX14 LEVETIRACETAM · form Tablet · route Oral · ingredients LEVETIRACETAM 500 MG · company Ucb canada inc · schedule Prescription
Ministry pays: $0.3911 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02247028)
Source record
DIN 02247028: Keppra
Raw flags: sec12=Y, sec3=Y
Item: 281200092; group id 434; item number 1084; lccId 00266; manufacturer id UCB
Source form: Tab; strength: 500mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.1725; ministry $0.3911
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02247028
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71263
Interchangeable products
Ach-Levetiracetam · DIN 02399784 · $0.3911
Act Levetiracetam · DIN 02274191 · $0.3911
Apo-Levetiracetam · DIN 02285932 · $0.3911
Auro-Levetiracetam · DIN 02375257 · $0.3911
Jamp Levetiracetam Tablets · DIN 02504561 · $0.3911
Jamp-Levetiracetam · DIN 02403021 · $0.3911
Levetiracetam · DIN 02353350 · $0.3911
Levetiracetam · DIN 02442558 · $0.3911
M-Levetiracetam · DIN 02524570 · $0.3911
Mint-Levetiracetam · DIN 02442396 · $0.3911
NRA-Levetiracetam · DIN 02499207 · $0.3911
PMS-Levetiracetam · DIN 02296128 · $0.3911
Riva-Levetiracetam · DIN 02482282 · $0.3911
Sandoz Levetiracetam · DIN 02461994 · $0.3911
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02247028
Shortage record checked October 6, 2026